The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.

Alessandro BroccoliLisa ArgnaniGabriele GugliottaCinzia PellegriniBeatrice CasadeiGianmarco BagnatoMarianna GentiliniVittorio StefoniPier Luigi Luigi Zinzani

Published in: The oncologist (2024)

Intensive treatment according to BFM protocol, with rituximab and ASCT, appears feasible, safe, and highly effective in adult patients with BL, as confirmed by long-term survival rates reflecting response maintenance.

Keyphrases

diffuse large b cell lymphoma
randomized controlled trial
stem cells
bone marrow
chronic lymphocytic leukemia